Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes

CONTEXT: Postprandial hyperglycemia remains a challenge in type 1 diabetes (T1D) due, in part, to dysregulated increases in plasma glucagon levels after meals. OBJECTIVE: This study was undertaken to examine whether 3 to 4 weeks of therapy with pramlintide or liraglutide might help to blunt postpran...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Endocrinol Metab
Autors principals: Galderisi, Alfonso, Sherr, Jennifer, VanName, Michelle, Carria, Lori, Zgorski, Melinda, Tichy, Eileen, Weyman, Kate, Cengiz, Eda, Weinzimer, Stuart, Tamborlane, William
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2017
Matèries:
Clinical Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6276715/
https://ncbi.nlm.nih.gov/pubmed/29211871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2017-02265
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars